Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-09-22

Clinical Trial Update: Methylene Blue and Ozone in Early Sepsis [Phase 4]

View source ↗

Summary

An ongoing Phase 4 clinical trial is evaluating methylene blue and medical ozone as therapies for early sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLENE BLUE (METHYLENE BLUE)
  • Medical ozone (Ozone)

Snippet

Sponsor: Assiut University | Conditions: Sepsis | Phase 4 | Status: UNKNOWN